TITLE:
Oxytocin and Uterine Atony during Cesarean Section
AUTHORS:
Loutfi Guennoun Abdelmounaim, A. Rjafallah, N. Nhiri, N. Biougnache, R. Benafitou, R. Barka, Y. Bouferma, S. Habib Rabbi, O. El Ayoubi, O. Alaoui, S. Mesnane, M. Khouchoua, S. Lafkir
KEYWORDS:
Oxytocin, Cesarean Section, Uterine Atony, Postpartum Hemorrhage
JOURNAL NAME:
Open Journal of Obstetrics and Gynecology,
Vol.11 No.6,
June
29,
2021
ABSTRACT: In our medical practice, in particular obstetrics, it is difficult to
change certain consolidated dogmas, but the necessity and the current situation
of our obstetrical exercise pushed us to find new technical supports, to make
the exercise of our specialty as stripped of pitfalls as possible. Our work is
summarized in a prospective comparative study, aimed at evaluating the existence
or not of a difference between the administration of oxytocin just before the
hysterotomy in a cesarean section and its administration after fetal
extraction. We used a set of criteria to include patients in our study. This
study took place over a period of one year (2020) in the Mother and Child
regional center, in Meknes Imperial city, Morocco, involving a total number of
364 patients. With a group A comprising 176 patients 48% (176/364) who received
oxytocin just before the hysterotomy and a group B of 188 patients 52%
(188/364) who received it classically after fetal extraction. The difference
was very significant as detailed in the article. Conclusion: the very
convincing results of our study and the difference between the two groups,
allowed us to demonstrate the effectiveness of our process and to endorse its
use in our routine practice, with the perspective of conducting a prospective
randomized study on a larger series.